Pages that link to "Q36902033"
Jump to navigation
Jump to search
The following pages link to Identification of a Novel Pathogenic Germline KDR Variant in Melanoma. (Q36902033):
Displaying 10 items.
- Towards standardization of next-generation sequencing of FFPE samples for clinical oncology: intrinsic obstacles and possible solutions. (Q36264188) (← links)
- Targeted next-generation sequencing identifies molecular subgroups in squamous cell carcinoma of the head and neck with distinct outcome after concurrent chemoradiation (Q38378172) (← links)
- Molecular subtype specific efficacy of MEK inhibitors in pancreatic cancers (Q42366316) (← links)
- Pilot assessment of vascular endothelial growth factor receptors and trafficking pathways in recurrent and metastatic canine subcutaneous mast cell tumours. (Q42682714) (← links)
- Cancer gene profiling in non-small cell lung cancers reveals activating mutations in JAK2 and JAK3 with therapeutic implications (Q47151526) (← links)
- Targeted molecular profiling of rare genetic alterations in colorectal cancer using next-generation sequencing. (Q48091765) (← links)
- Analysis of clinically relevant somatic mutations in high-risk head and neck cutaneous squamous cell carcinoma. (Q48233207) (← links)
- Expanded molecular profiling of myxofibrosarcoma reveals potentially actionable targets (Q48292408) (← links)
- Molecular Screening of Small Biopsy Samples Using Next-Generation Sequencing in Korean Patients with Advanced Non-small Cell Lung Cancer: Korean Lung Cancer Consortium (KLCC-13-01). (Q52724325) (← links)
- The identification of patient-specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild-type melanomas (Q90611117) (← links)